Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Page 5 of 9« First...34567...Last »

Boehringer Ingelheim Vetmedica Will Move North American HQ to Georgia, Bulk of Employees Will Remain Unaffected

Boehringer Ingelheim Vetmedica announced that as part of the integration of Merial, it was locating its North American and U.S. Animal Health headquarters in Duluth, Georgia.

Read More »

China Takes Lead in CRISPR Race

China has taken the lead in CRISPR research as an oncology team in that country became the first to inject cells that contained edited genes using the technology.

Read More »

Huge study finds a billion people suffer from high blood pressure

The number of people with high blood pressure has almost doubled in 40 years to over 1.1 billion worldwide, scientists said, with the burden of the condition shifting from the rich to the poor.

Read More »

Diet sodas might not raise diabetes risk

Drinking colas and other sugary drinks is tied to an increased risk of so-called pre-diabetes – a precursor to full-blown disease – but diet soda is not, a recent study suggests.

Read More »

Long-lasting cholesterol lowering in drug study

A new type of heart drug developed by The Medicines Co. significantly lowered “bad” LDL cholesterol in high-risk patients with no major safety issues.

Read More »

Cholesterol drug reduces artery-clogging plaque

Amgen’s Repatha with statin therapy took “bad” LDL cholesterol down to extremely low levels and caused artery-clogging plaque decline after 18 months’ treatment.

Read More »

Family Tree DNA Offers First Commercially Available DNA Test to Reveal Ancient European Origins

This latest enhancement to the popular Family Finder test complements the myOrigins mapping tool which provides an ethnic and geographic breakdown of a where a person’s ancestors came from, and the updated Family Matching tool which allows users to sort confirmed DNA matches by paternal and maternal lines.

Read More »

uniQure Shakes Up R&D to Refocus Pipeline, to Eliminate 20-25% of Workforce By End of 2017

uniQure NV recently completed a strategic review with a decision to refocus its pipeline and cut 20 to 25 percent of its workforce.

Read More »

Top 10 Amgen Scholars to Watch Set to Impact the Future of Science and Medicine

It’s been 10 years since the Amgen Scholars Program was put into place, with more than 3,000 students participating. After a decade, the foundation has tagged 10 participants for its Ten to Watch list who are likely to play big roles in the science and medical industries.

Read More »

Puma Biotech Crashes After Diarrhea Risk is Linked to Breast Cancer Drug

Puma Biotechnology shares plummeted after the company disclosed patients taking its experimental breast cancer drug neratinib may require a second drug to prevent serious diarrhea.

Read More »

Roche launches cancer immunotherapy research network

Roche has launched a global cancer immunotherapy Centers of Research Excellence network, saying it will invest up to 100 million Swiss francs ($100.3 million) in the project.

Read More »

Heredity is not always destiny when it comes to heart attacks: study

If heredity puts you at higher risk for a heart attack, maintaining a healthy lifestyle can bring that risk down dramatically – below the risk faced by some people whose genes would normally protect them from heart disease – according to a new analysis of more than 55,000 people.

Read More »

Computer-brain interface helps locked-in patient communicate, albeit slowly

Doctors in the Netherlands say they have successfully tested an implantable computer-brain interface that allowed the mind of a “locked-in” patient to spell messages at the rate of two letters per minute.

Read More »

FDA rejects Dynavax’s hepatitis B vaccine

The U.S. Food and Drug Administration rejected Dynavax Technologies Corp.’s hepatitis B vaccine for the second time in three years.

Read More »

The Novartis house that Vasella built gets extreme makeover

Signals from Swiss drugmaker Novartis that it could unload its struggling Alcon eyecare business is the latest step in dismantling former leader Dan Vasella’s vision of building a European healthcare giant.

Read More »

Corbus drug succeeds in scleroderma study

Corbus Pharmaceuticals Holdings Inc. said its only drug outperformed a placebo in a mid-stage study involving patients with a form of systemic sclerosis.

Read More »

With Bristol-Myers Squibb, Genentech and Merck & Co. Expanding in the Bay Area, Some Wonder if the Real Estate Boom is Too Much

Biotech construction in the San Francisco Bay Area is booming, as it is in Boston. Merck may have a deal for 300,000 square feet in South San Francisco. Genentech, part of the Roche Group, acquired four buildings it had been leasing and is potentially acquiring four more.

Read More »

Celgene Exec Out as Trump Puts Vice President Elect Leader of Transition Effort

Celgene executive Rich Bagger will return to the private sector. That was the message President-elect Donald Trump’s transition team told the New York Times.

Read More »

Pfizer offers cut-price pneumonia shot for humanitarian crises

U.S. pharmaceuticals giant Pfizer is to offer its pneumococcal vaccine at the lowest possible price to non-governmental organizations seeking to protect vulnerable people from illness in humanitarian crises.

Read More »

Trump Promises to “Reform the FDA”

The President-Elect Donald Trump Administration has a new website and has updated – sort of – Trump’s intended policies for healthcare and biopharma.

Read More »

Page 5 of 9« First...34567...Last »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2018 Focus: Top 200 Meds, Year After Launch, VR/AR and more!


Ad Right Bottom